Gulf International Bank (UK)’s Royalty Pharma RPRX Stock Holding History

Gulf International Bank (UK)’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.74M	Sell	30,958 -289	-0.9%	-$15K	0.03%	406
2026 Q1	$1.5M	Buy	31,247 +9,373	+43%	+$411K	0.03%	416
2025 Q4	$845K	Hold	21,874	–	–	0.03%	474
2025 Q3	$772K	Sell	21,874 -602	-3%	-$21.8K	0.03%	494
2025 Q2	$809K	Hold	22,476	–	–	0.03%	478
2025 Q1	$699K	Sell	22,476 -7,281	-24%	-$231K	0.02%	521
2024 Q4	$759K	Sell	29,757 -769	-3%	-$20.4K	0.02%	527
2024 Q3	$863K	Sell	30,526 -945	-3%	-$26.2K	0.02%	519
2024 Q2	$829K	Hold	31,471	–	–	0.02%	518
2024 Q1	$955K	Hold	31,471	–	–	0.02%	503
2023 Q4	$884K	Sell	31,471 -3,415	-10%	-$93.8K	0.02%	515
2023 Q3	$946K	Sell	34,886 -2,949	-8%	-$87.6K	0.03%	503
2023 Q2	$1.16M	Sell	37,835 -8,635	-19%	-$292K	0.03%	480
2023 Q1	$1.67M	Sell	46,470 -11,760	-20%	-$436K	0.03%	450
2022 Q4	$2.3M	Buy	58,230 +650	+1%	+$27.1K	0.04%	425
2022 Q3	$2.31M	Hold	57,580	–	–	0.04%	402
2022 Q2	$2.42M	Hold	57,580	–	–	0.04%	411
2022 Q1	$2.24M	Buy	57,580 +300	+0.5%	+$11.8K	0.03%	470
2021 Q4	$2.28M	Buy	57,280 +19,893	+53%	+$773K	0.03%	482
2021 Q3	$1.35M	Hold	37,387	–	–	0.02%	603
2021 Q2	$1.53M	Hold	37,387	–	–	0.02%	605
2021 Q1	$1.63M	Buy	37,387 +29,545	+377%	+$1.4M	0.02%	579
2020 Q4	$392K	Buy	+7,842	New	+$333K	0.01%	663

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Gulf International Bank (UK)'s RPRX Position: Q2 2026 in Review

Gulf International Bank (UK) reduced its Royalty Pharma (RPRX) stake by 0.92% in Q2 2026, selling an estimated $15K and leaving 30,958 shares worth $1.74M. The position accounts for 0.03% of the portfolio, ranked #406.

Gulf International Bank (UK) first reported a position in RPRX in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.42M in Q2 2022. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Gulf International Bank (UK) held 30,958 shares of Royalty Pharma worth $1.74M as of Q2 2026.
Gulf International Bank (UK) sold 289 Royalty Pharma shares in Q2 2026, an estimated $15K.
Royalty Pharma made up 0.03% of Gulf International Bank (UK)'s portfolio in Q2 2026, its #406 holding.
Gulf International Bank (UK) first reported a position in Royalty Pharma in Q4 2020 and has held it in 23 quarters since.
Gulf International Bank (UK)'s Royalty Pharma position peaked at $2.42M in Q2 2022.
647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Gulf International Bank (UK)'s 13F filing for Q2 2026, filed 13 Aug 2026.